Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Description of Relugolix Use in Patients With Prostate Cancer: An Analysis of National Veterans Affairs Health Care Network Data

NCT06462014 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06462014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06462014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Description of Relugolix Use in Patients With Prostate Cancer: An Analysis of National Veterans Affairs Health Care Network Data
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 19, 2024
Completion date
December 13, 2024
Enrollment
507 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer